Prostacyclin and iloprost do not affect action of standard dose heparin on haemostatic function during haemodialysis

作者: J.B Dibble , P.A Kalra , M.A Orchard , J.H Turney , J.A Davies

DOI: 10.1016/0049-3848(88)90241-1

关键词:

摘要: Abstract The actions of prostacyclin and iloprost, as supplements to heparin therapy, were examined by measuring indices blood coagulation platelet activation during the first two hours haemodialysis in six patients with stable chronic renal failure. Patients received either 5 ng kg −1 min , iloprost 2 or placebo at random on three separate occasions a supplement standard therapy 50 I.U. loading dose 30 hr infusion. Neither nor significantly affected dialysis induced changes whole count plasma concentrations β thromboglobulin, (βTG) factor 4 (PF4), fibrinogen fibrinopeptide A. Thus still fell 12 ± 8% within 15 start dialysis, slowly returning initial over study period PF4 increased nearly 10 fold same time. In addition, serial measurements KCCT failed indicate any sparing effect prostanoids this heparin.

参考文章(17)
Curtis, Ireland H, Lane Da, Objective assessment of heparin requirements for hemodialysis in humans. Journal of Laboratory and Clinical Medicine. ,vol. 103, pp. 643- ,(1984)
Laurence A. Harker, Arthur R. Thompson, Manual of Hemostasis and Thrombosis ,(1983)
J. Dawes, R.C. Smith, D.S. Pepper, The release, distribution, and clearance of human β-thromboglobulin and platelet factor 4 Thrombosis Research. ,vol. 12, pp. 851- 861 ,(1978) , 10.1016/0049-3848(78)90279-7
A. Clauss, Rapid physiological coagulation method in determination of fibrinogen Acta Haematologica. ,vol. 17, pp. 237- 246 ,(1957) , 10.1159/000205234
Jørn Dyerberg, Flemming Knudsen, ArneH. Nielsen, HansJ. Kornerup, JensC. Pedersen, Epoprostenol as sole antithrombotic treatment during haemodialysis. The Lancet. ,vol. 324, pp. 235- 236 ,(1984) , 10.1016/S0140-6736(84)90529-4
Dilip Basu, Alexander Gallus, Jack Hirsh, John Cade, A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin Time New England Journal of Medicine. ,vol. 287, pp. 324- 327 ,(1972) , 10.1056/NEJM197208172870703
J.H. Turney, M.R. Fewell, L.C. Williams, V. Parsons, M.J. Weston, Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy. The Lancet. ,vol. 316, pp. 219- 222 ,(1980) , 10.1016/S0140-6736(80)90116-6
P.B Rylance, M.P Gordge, A.M Keogh, V Parsons, M.J Weston, EPOPROSTENOL DURING HAEMODIALYSIS The Lancet. ,vol. 324, pp. 744- 745 ,(1984) , 10.1016/S0140-6736(84)92643-6
Michael C. Smith, Kowit Danviriyasup, James W. Crow, Allen E. Cato, Glen D. Park, Aviv Hassid, Michael J. Dunn, Prostacyclin substitution for heparin in long-term hemodialysis. The American Journal of Medicine. ,vol. 73, pp. 669- 678 ,(1982) , 10.1016/0002-9343(82)90409-0
J.H. Turney, M.J. Weston, DIALYSIS WITHOUT ANTICOAGULANTS The Lancet. ,vol. 318, pp. 693- ,(1981) , 10.1016/S0140-6736(81)91022-9